Philips Buys Respironics For $5.1 Bil. To Build Home Health Care Business
This article was originally published in The Gray Sheet
Executive Summary
Philips will add obstructive sleep apnea and respiratory care products to its burgeoning home health care franchise through the $5.1 billion acquisition of Respironics, announced Dec. 21
You may also be interested in...
Regional Carriers Delay Coverage Policy On Home Testing Of Sleep Apnea
Regional Medicare administrative contractors are delaying implementation of a local coverage policy intended to expand reimbursement of continuous positive airway pressure (CPAP) devices, the contractors announced Aug 22
Regional Carriers Delay Coverage Policy On Home Testing Of Sleep Apnea
Regional Medicare administrative contractors are delaying implementation of a local coverage policy intended to expand reimbursement of continuous positive airway pressure (CPAP) devices, the contractors announced Aug 22
GE Gains Sleep Apnea, Anesthesia Products In $860 Mil. Vital Signs Purchase
GE Healthcare's $860 million acquisition of Vital Signs Inc. provides an entry into the rapidly growing sleep apnea market and complementary offerings for its anesthesia and broader respiratory care businesses